Effect of glycemic control and disease duration on cardiac autonomic function and oxidative stress in type 2 diabetes mellitus
Open accessAbstract
Purpose Cardiac autonomic neuropathy (CAN) is a commonly overlooked complication of type 2 diabetes mellitus (T2DM), with a complex pathogenesis involving hyperglycemia-induced oxidative stress which results in neuronal ischemia and cellular death. The level of hyperglycemia as well as disease duration might be significant determinants of the prognosis of T2DM, but limited studies have explored their relationship with these diabetic complications. Therefore, the purpose of this study was to examine the effect of glycemic control and disease duration on cardiac autonomic function and oxidative stress in patients with T2DM.Methods 60 T2DM patients along with 63 healthy controls were recruited for the study. Diabetic patients were further classified based on glycemic control (HbA1c levels <8% vs. ≥8%) and disease duration (<5 vs. 5-10 vs. >10 years). All participants were assessed for cardiac autonomic function (HRR: heart rate recovery; HRV: heart rate variability), levels of antioxidant enzymes (CAT: catalase; SOD: superoxide dismutase), serum nitric oxide (NO) and other cardiometabolic risk factors (resting blood pressure, glycemic and lipid profile).Results T2DM patients showed a significant reduction in HRR, HRV, CAT, SOD and an increase in LFnu, LF: HF ratio and NO. These impairments were significantly greater for the group with poor glycemic control (p < 0.05). However, no difference for these parameters was observed with respect to different disease durations.Conclusion Cardiac autonomic regulation and endogenous antioxidant defense were compromised and levels of nitric oxide found to be raised in patients with Type 2 diabetes. These findings were more pronounced in subjects with poor glycemic control.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Both diabetes mellitus and prediabetes are independently associated with lower heart rate variability (HRV).
“Both DM and prediabetes are independently associated with lower heart rate variability (HRV), which suggests that cardiac autonomic dysfunction may be characteristic of prediabetes2–5.”
From Sleep and temperature data from wearable devices support noninvasive detection of diabetes mellitus in a large-scale, retrospective analysis (2026) · cites this paper as [5]
The “Effect of DM” section (page unavailable) reports reduced HRV measures in people with type 2 diabetes compared with non-diabetic controls. The cited paper does not report a separate prediabetes group or establish an independent association between prediabetes and lower HRV. (LLM, conf=0.88)
Experimental — accuracy not yet measuredPrior work chiefly assessed statistical aggregation functions of wearable data streams (primary features), which are nonspecific to the effects of DM within data streams that are constantly fluctuating in natural settings.
“Third, prior work chiefly assessed statistical aggregation functions of wearable data streams (primary features)5,26–32, which are nonspecific to the effects of DM within data streams that are constantly fluctuating in natural settings.”
From Sleep and temperature data from wearable devices support noninvasive detection of diabetes mellitus in a large-scale, retrospective analysis (2026) · cites this paper as [5]
The Cardiac autonomic function section (page unavailable) describes time- and frequency-domain measures calculated from a five-minute ECG recording, supporting the use of summary features. But the recording was made under controlled conditions, not from wearable streams in natural settings. The paper does not assess whether those features are nonspecific to diabetes or establish what prior work chiefly assessed. (LLM, conf=0.84)
Experimental — accuracy not yet measuredPrior work was generated from small cohorts (the largest cohort of 70 individuals), raising questions of the generalizability of their findings.
“Second, prior work was generated from small cohorts (the largest cohort of 70 individuals), that raise questions of the generalizability of their findings5,22–32.”
From Sleep and temperature data from wearable devices support noninvasive detection of diabetes mellitus in a large-scale, retrospective analysis (2026) · cites this paper as [5]
The Limitations and future perspective section says the study’s small sample size limits generalizability. But the Sample size section reports 123 participants—60 patients and 63 controls—so this paper does not support describing 70 individuals as the largest cohort across the cited prior work. (LLM, conf=0.88)
Experimental — accuracy not yet measuredPrior work typically uses less than a day of input.
“First, where prior work typically uses less than a day of input5,22–32, we assess the impact of longitudinal input windows ranging up to multiple weeks and demonstrate improved sensitivity with longer windows (AUROC increases by 0.15 from 1-night to 21-night models, in balanced and imbalanced cohorts).”
From Sleep and temperature data from wearable devices support noninvasive detection of diabetes mellitus in a large-scale, retrospective analysis (2026) · cites this paper as [5]
Features of heart rate, heart rate variability, movement, and electrodermal activity extracted from wearable data have been applied to detect hypoglycemic events in cohorts ranging from 1 to 36 individuals.
“Features of HR, HRV, movement, and electrodermal activity (EDA; a measure of perspiration) extracted from wearable data have been applied to detect hypoglycemic events in cohorts ranging from 1 to 36 individuals5,26–28.”
From Sleep and temperature data from wearable devices support noninvasive detection of diabetes mellitus in a large-scale, retrospective analysis (2026) · cites this paper as [5]
The Cardiac autonomic function section (page unavailable) describes HR and HRV measurements from ECG during an exercise test, not features extracted from wearable data to detect hypoglycemic events. Searches for wearable hypoglycemia detection and electrodermal activity found no passage addressing that application or cohorts of 1–36 individuals. (LLM, conf=0.75)
Experimental — accuracy not yet measured
Our data is more representative of real-world performance than prior work because we captured a broader population segment with larger cohorts.
“While prior work reported higher performance, our data is more representative of real-world performance as we captured a broader population segment with our larger cohorts (balanced cohort is 5× and imbalanced cohort is 91× the largest prior cohort of wearable data)5,29–32.”
From Sleep and temperature data from wearable devices support noninvasive detection of diabetes mellitus in a large-scale, retrospective analysis (2026) · cites this paper as [5]
The cited paper's Sample size section describes 123 participants, and its Cardiac autonomic function section describes ECG recordings rather than wearable data. Its Limitations and future perspective section says the small sample limits generalizability. A search for wearable cohorts and comparative performance found no passage addressing the prior-work comparison for which this citation is offered; the citing authors' claim about their own cohorts is not a finding attributed to this source. (LLM, conf=0.76)
Experimental — accuracy not yet measuredThe balanced cohort is 5 times and the imbalanced cohort is 91 times the largest prior cohort of wearable data.
“balanced cohort is 5× and imbalanced cohort is 91× the largest prior cohort of wearable data”
From Sleep and temperature data from wearable devices support noninvasive detection of diabetes mellitus in a large-scale, retrospective analysis (2026) · cites this paper as [5]
The Sample size section reports 123 participants—60 with type 2 diabetes and 63 controls—and the Limitations and future perspective section calls this a small sample. Searches for the stated 5× and 91× comparisons and for balanced, imbalanced wearable-data cohorts found no passage addressing them. Page numbers were not available in our copy. (LLM, conf=0.78)
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
International Diabetes Federation 2017
Carracher, A. M., Marathe, P. H., & Close, K. L. (2018) · Journal of Diabetes · doi:10.1111/1753-0407.12644 · Cited by 13,369 · see citing works
Biochemistry and molecular cell biology of diabetic complications
Brownlee, M. (2001) · Nature · doi:10.1038/414813a · Cited by 9,107 · see citing works
Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802987 · Cited by 7,397 · see citing works
Glucose control and vascular complications in veterans with type 2 diabetes
Duckworth, W., Abraira, C., Moritz, T., Reda, D., Emanuele, N., Reaven, P. D., Zieve, F. J., Marks, J., Davis, S. N., Hayward, R., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808431 · Cited by 4,762 · see citing works
Standards of Medical Care in Diabetes—2012
(2012) · Diabetes Care · doi:10.2337/dc12-s011 · Cited by 2,240 · see citing works
2. Classification and Diagnosis of Diabetes
American Diabetes Association (2017) · Diabetes Care · doi:10.2337/dc17-s005 · Cited by 1,603 · see citing works
Ismail-Beigi, F., Craven, T., Banerji, M. A., Basile, J., Calles, J., Cohen, R. M., Cuddihy, R., Cushman, W. C., Genuth, S., Grimm, R. H., et al. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60576-4 · Cited by 1,428 · see citing works
Primary Prevention of Cardiovascular Diseases in People With Diabetes Mellitus
Buse, J. B., Ginsberg, H. N., Bakris, G. L., Clark, N. G., Costa, F., Eckel, R., Fonseca, V., Gerstein, H. C., Grundy, S., Nesto, R. W., et al. (2007) · Diabetes Care · doi:10.2337/dc07-9917 · Cited by 1,055 · see citing works
Primary Prevention of Cardiovascular Diseases in People With Diabetes Mellitus
Buse, J. B., Ginsberg, H. N., Bakris, G. L., Clark, N. G., Costa, F., Eckel, R. H., Fonseca, V. A., Gerstein, H. C., Grundy, S. M., Nesto, R. W., et al. (2006) · Circulation · doi:10.1161/circulationaha.106.179294 · Cited by 629 · see citing works
Obesity-related non-communicable diseases: South Asians vs White Caucasians
Misra, A., & Khurana, L. (2011) · International Journal of Obesity · doi:10.1038/ijo.2010.135 · Cited by 491 · see citing works
Association of hyperglycemia with reduced heart rate variability (The Framingham Heart Study)
Singh, J. P., Larson, M. G., O’Donnell, C. J., Wilson, P. F., Tsuji, H., Lloyd-Jones, D. M., & Levy, D. (2000) · The American Journal of Cardiology · doi:10.1016/s0002-9149(00)00920-6 · Cited by 439 · see citing works
Spectral analysis of heart rate variability in the assessment of autonomic diabetic neuropathy
Pagani, M., Malfatto, G., Pierini, S., Casati, R., Masu, A. M., Poli, M., Guzzetti, S., Lombardi, F., Cerutti, S., & Malliani, A. (1988) · Journal of the Autonomic Nervous System · doi:10.1016/0165-1838(88)90078-1 · Cited by 378 · see citing works
Cardiac autonomic neuropathy in patients with diabetes mellitus
Dimitropoulos, G. (2014) · World Journal of Diabetes · doi:10.4239/wjd.v5.i1.17 · Cited by 364 · see citing works
Glycemic control and complications in type 2 diabetes mellitus
Stolar, M. (2010) · The American Journal of Medicine · doi:10.1016/j.amjmed.2009.12.004 · Cited by 356 · see citing works
Association of Diabetes, Comorbidities, and A1C With Functional Disability in Older Adults
Kalyani, R. R., Saudek, C. D., Brancati, F. L., & Selvin, E. (2010) · Diabetes Care · doi:10.2337/dc09-1597 · Cited by 336 · see citing works
Ceriello, A., Russo, P. D., Amstad, P., & Cerutti, P. (1996) · Diabetes · doi:10.2337/diab.45.4.471 · Cited by 324 · see citing works
Aydın, A., Orhan, H., Sayal, A., Özata, M., Şahin, G., & Işimer, A. (2001) · Clinical Biochemistry · doi:10.1016/s0009-9120(00)00199-5 · Cited by 301 · see citing works
Enhanced serum levels of thiobarbituric-acid-reactive substances in diabetes mellitus
Griesmacher, A., Kindhauser, M., Andert, S. E., Schreiner, W., Toma, C. D., Knöbl, P., Pietschmann, P., Prager, R., Schnack, C., Schemthaner, G., et al. (1995) · The American Journal of Medicine · doi:10.1016/s0002-9343(99)80347-7 · Cited by 300 · see citing works
Trends in the prevalence and incidence of diabetes in the UK: 1996–2005
Gonzalez, E., Johansson, S., Wallander, M. ‐., & Rodríguez, L. A. G. (2009) · Journal of Epidemiology & Community Health · doi:10.1136/jech.2008.080382 · Cited by 295 · see citing works
Oxidative stress and insulin action: is there a relationship?
Paolisso, G., & Giugliano, D. (1996) · Diabetologia · doi:10.1007/bf00418354 · Cited by 294 · see citing works
Role of Advanced Glycation End Products and Their Receptors in Development of Diabetic Neuropathy
Wada, R., & Yagihashi, S. (2005) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1338.067 · Cited by 264 · see citing works
Nitric Oxide Modulates Superoxide Release and Peroxynitrite Formation in Human Blood Vessels
Guzik, T. J., West, N. E. J., Pillai, R. G., Taggart, D. P., & Channon, K. M. (2002) · Hypertension · doi:10.1161/01.hyp.0000018041.48432.b5 · Cited by 264 · see citing works
Piconi, L., Quagliaro, L., & Ceriello, A. (2003) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2003.177 · Cited by 255 · see citing works
Bernardi, L., Ricordi, L., Lazzari, P., Soldà, P. L., Calciati, A., Ferrari, M. R., Vandea, I., Finardi, G., & Fratino, P. (1992) · Circulation · doi:10.1161/01.cir.86.5.1443 · Cited by 237 · see citing works
Fujimoto, M., Shimizu, N., Kunii, K., Martyn, J. A. J., Ueki, K., & Kaneki, M. (2005) · Diabetes · doi:10.2337/diabetes.54.5.1340 · Cited by 209 · see citing works
Antioxidant enzyme alterations in experimental and clinical diabetes
Godin, D. V., Wohaieb, S. A., Garnett, M. E., & Goumeniouk, A. D. (1988) · Molecular and Cellular Biochemistry · doi:10.1007/bf00421057 · Cited by 206 · see citing works
Nitric Oxide Synthesis Is Reduced in Subjects With Type 2 Diabetes and Nephropathy
Tessari, P., Cecchet, D., Cosma, A., Vettore, M., Coracina, A., Millioni, R., Iori, E., Puricelli, L., Avogaro, A., & Vedovato, M. (2010) · Diabetes · doi:10.2337/db09-1772 · Cited by 187 · see citing works
Association of vagal tone with serum insulin, glucose, and diabetes mellitus — The ARIC Study
Liao, D., Cai, J., Brancati, F. L., Folsom, A., Barnes, R. W., Tyroler, H. A., & Heiss, G. (1995) · Diabetes Research and Clinical Practice · doi:10.1016/0168-8227(95)01190-0 · Cited by 159 · see citing works
Oxidative stress, antioxidant status and lipid profile in the saliva of type 2 diabetics
Al-Rawi, N. H. (2011) · Diabetes and Vascular Disease Research · doi:10.1177/1479164110390243 · Cited by 148 · see citing works
Tk, S., Singh, I., Singh, N., Vardey, G., Kumawat, M., Ghalaut, V., & Shankar, V. (2013) · North American Journal of Medical Sciences · doi:10.4103/1947-2714.109193 · Cited by 143 · see citing works
Jelinek, H. F., Osman, W. M., Khandoker, A. H., Khalaf, K. A., Lee, S., Almahmeed, W. A., & AlSafar, H. S. (2017) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2017-000427 · Cited by 132 · see citing works
Lipid peroxidation and antioxidant enzyme activities in erythrocytes of type 2 diabetic patients.
Likidlilid, A., Patchanans, N., Peerapatdit, T., & Sriratanasathavorn, C. (2010) · PubMed · Cited by 129 · see citing works
Pappachan, J. M., Sebastian, J., Bino, B. C., Jayaprakash, K., Vijayakumar, K., Sujathan, P., & Abas, A. L. (2008) · Postgraduate Medical Journal · doi:10.1136/pgmj.2007.064048 · Cited by 127 · see citing works
Hyperglycaemia Enhances Nitric Oxide Production in Diabetes: A Study from South Indian Patients
Adela, R., Nethi, S. K., Bagul, P. K., Barui, A. K., Mattapally, S., Kuncha, M., Patra, C. R., Reddy, P. N. C., & Banerjee, S. (2015) · PLoS ONE · doi:10.1371/journal.pone.0125270 · Cited by 122 · see citing works
Dinçer, Y., Akçay, T., Alademir, Z., & ILKOVA, H. M. (2002) · Metabolism · doi:10.1053/meta.2002.35192 · Cited by 115 · see citing works
Renal antioxidant enzyme mRNA levels are increased in rats with experimental diabetes mellitus
Sechi, L. A., Ceriello, A., Griffin, C. A., Catena, C., Amstad, P., Schambelan, M., & Bartoli, E. (1997) · Diabetologia · doi:10.1007/s001250050638 · Cited by 85 · see citing works
Exercise and NO production: relevance and implications in the cardiopulmonary system
Носарев, А. В., Smagliy, L. V., Anfinogenova, Y., Popov, S. V., & Капилевич, Л. В. (2015) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2014.00073 · Cited by 81 · see citing works
Plasma antioxidants and type 2 diabetes mellitus.
Palanduz, Ş., Ademoğlu, E., Gökkuşu, C., & Tamer, Ş. (2001) · PubMed · Cited by 71 · see citing works
Review Paper: Oxidative Stress Evaluation in Diabetes
Mercuri, F., Quagliaro, L., & Ceriello, A. (2000) · Diabetes Technology & Therapeutics · doi:10.1089/15209150050502014 · Cited by 71 · see citing works
Rothberg, L. J., Lees, T., Clifton-Bligh, R. J., & Lal, S. (2016) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2016.0010 · Cited by 57 · see citing works
Sacre, J. W., Jellis, C. L., Coombes, J. S., & Marwick, T. H. (2012) · Diabetic Medicine · doi:10.1111/j.1464-5491.2012.03719.x · Cited by 40 · see citing works
QTc and autonomic neuropathy in diabetes: Effects of acute hyperglycaemia and n-3 PUFA
Santini, V., Ciampittiello, G., Gigli, F., Bracaglia, D., Baroni, A., Cicconetti, E., Verri, C., Gambardella, S., & Frontoni, S. (2007) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2006.09.006 · Cited by 37 · see citing works
Serum nitric oxide status in patients with type 2 diabetes mellitus in Sikkim
Pal, R., Ghosh, A., Sherpa, M. L., Bhutia, Y., & Dahal, S. (2011) · International Journal of Applied and Basic Medical Research · doi:10.4103/2229-516x.81977 · Cited by 37 · see citing works
Lipoperoxidation and antioxidant capacity in patients with poorly controlled type 2 diabetes
Lodovici, M., Bigagli, E., Bardini, G., & Rotella, C. M. (2009) · Toxicology and Industrial Health · doi:10.1177/0748233709106464 · Cited by 37 · see citing works
Relation Between Plasma Nitric Oxide Levels and Diabetic Retinopathy
Izumi, N., Nagaoka, T., Mori, F., Sato, E., Takahashi, A., & Yoshida, A. (2006) · Japanese Journal of Ophthalmology · doi:10.1007/s10384-006-0344-y · Cited by 37 · see citing works
Madi, M., Babu, S., Kumari, S., Shetty, S. R., Achalli, S., Madiyal, A., & Bhat, M. (2016) · Ethiopian Journal of Health Sciences · doi:10.4314/ejhs.v26i6.4 · Cited by 31 · see citing works
Bigagli, E., Raimondi, L., Mannucci, E., Colombi, C., Bardini, G., Rotella, C. M., & Lodovici, M. (2012) · The British Journal of Diabetes · doi:10.1177/1474651411435588 · Cited by 28 · see citing works
Hazari, M. A. H., Khan, R. T., Reddy, B. R., & Hassan, M. A. (2012) · Neurosciences · doi:10.17712/1658-3183.1944 · Cited by 28 · see citing works
Pietro, N. D., Tomo, P. D., Silvestre, S. D., Giardinelli, A., Pipino, C., Morabito, C., Formoso, G., Mariggiò, M. A., & Pandolfi, A. (2012) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2012.10.062 · Cited by 27 · see citing works
Nitric oxide levels in response to the patients with different stage of diabetes
Özçelik, O., & Algül, Ş. (2017) · Cellular and Molecular Biology · doi:10.14715/cmb/2017.63.1.10 · Cited by 24 · see citing works
Complexity of heart rate variability in type 2 diabetes - effect of hyperglycemia
Tarvainen, M. P., Cornforth, D. J., Kuoppa, P., Lipponen, J. A., & Jelinek, H. F. (2013) · Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC) · doi:10.1109/embc.2013.6610809 · Cited by 18 · see citing works
Co-Existence of hypertension worsens post-exercise cardiac autonomic recovery in type 2 diabetes
Verma, S., Bhati, P., Ahmad, I., Masroor, S., Ali, K., Singla, D., & Hussain, M. E. (2018) · Indian Heart Journal · doi:10.1016/j.ihj.2018.06.007 · Cited by 11 · see citing works
Self-citationVerma, S., Moiz, J. A., Anwer, S., Alghadir, A. H., & Hussain, M. E. (2018) · Trials · doi:10.1186/s13063-018-2671-y · Cited by 9 · see citing works
Self-citation
Flagged first, then by citations
Research works printed but not linked: 1
- Dincer Y, Akcay T, Alademir Z, Ilkova H. Effect of oxidative stress on glutathione pathway in RBCs from patients with IDDM. Metabolism. 2002;51:1360-2.
Cited by
Sorted by citations
Bakkar, N. Z., Dwaib, H. S., Fares, S. A., Eid, A. H., Al-Dhaheri, Y., & EL‐Yazbi, A. F. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21239005 · Cited by 74 · see citing works
Martins, M. D. C. D. C. E., Martins, M., Oliveira, A. S. D. S. S., da Silva, L. A. A., Primo, M. G. S., & de Carvalho, V. B. L. (2022) · Biomarkers in disease · doi:10.1007/978-3-030-81304-8_49-1 · Cited by 52 · see citing works
Cojić, M., Kocić, R., Klisic, A. N., Kezunović, L. C., Kavarić, N., & Kocic, G. M. (2020) · Archives of Medical Science · doi:10.5114/aoms.2020.92832 · Cited by 26 · see citing works
Martins, M. D. C. D. C. E., Oliveira, A. S. D. S. S., da Silva, L. A. A., Primo, M. G. S., & de Carvalho, V. B. L. (2022) · Biomarkers in disease · doi:10.1007/978-3-031-07389-2_49 · Cited by 24 · see citing works
Aspartic acid supplementation ameliorates symptoms of diabetic kidney disease in mice
Ichikawa, S., Gohda, T., Murakoshi, M., Li, Z., Adachi, E., Koshida, T., & Suzuki, Y. (2020) · FEBS Open Bio · doi:10.1002/2211-5463.12862 · Cited by 20 · see citing works
Lin, K., Chang, L.-H., Wu, Y.-R., Hsu, W., Kuo, C., Tsai, J., Yu, M., Su, W.-S., & Lin, I. (2022) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2022.108264 · Cited by 20 · see citing works
Patoulias, D., Katsimardou, A., Fragakis, N., Papadopoulos, C. E., & Doumas, M. N. (2022) · Acta Diabetologica · doi:10.1007/s00592-022-01958-0 · Cited by 17 · see citing works
John, A. P., Udupa, K., Avangapur, S., Sujan, M. U., Inbaraj, G., Vasuki, P. P., Mahadevan, A., Anilkumar, R., Shekar, M. A., & Sathyaprabha, T. N. (2022) · PubMed Central · Cited by 13 · see citing works
Silva, L., Gentil, P., Seguro, C. S., Teles, G. D. O., Silva, M. S., Zamunér, A. R., Beltrame, T., & Rebelo, A. C. S. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.760292 · Cited by 11 · see citing works
Camille, M., Nganou–Gnindjio, C. N., Azabji‐Kenfack, M., Mfeukeu‐Kuate, L., Dehayem, M. Y., Mbanya, J. C., & Sobngwi, E. (2019) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2019.107875 · Cited by 10 · see citing works
Association of leukocyte telomere length with metabolic syndrome in type 2 diabetes mellitus
Peng, X., Huang, J., Xia, S.-S., Yang, Y., & Dong, K. (2021) · Journal of Research in Medical Sciences · doi:10.4103/jrms.jrms_793_20 · Cited by 8 · see citing works
Evans, A. J., & Li, Y. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252212464 · Cited by 7 · see citing works
Chang, R.-Y., Tsai, H., Hsiao, P.-G., Tan, C.-W., Lee, C., Chu, I., Chen, Y., & Koo, M. (2019) · PLoS ONE · doi:10.1371/journal.pone.0222236 · Cited by 7 · see citing works
Wu, Y.-R., Su, W.-S., Lin, K., & Lin, I. (2024) · Applied Psychophysiology and Biofeedback · doi:10.1007/s10484-024-09666-x · Cited by 5 · see citing works
A Comparative Analysis of Superoxide Dismutase 1 Level in Diabetics with and without Neuropathy
Huma, K., Mehboob, K., Rashid, A., & Majeed, A. (2021) · Journal of College of Physicians And Surgeons Pakistan · doi:10.29271/jcpsp.2021.07.765 · Cited by 2 · see citing works
Shobhawat, M., Srivastav, S., Shukla, R. K. G., & Bhagat, O. L. (2025) · Annals of Neurosciences · doi:10.1177/09727531251384548 · Cited by 1 · see citing works
Viswanath, V. K., Navaneethan, S., Burks, J. H., Soltani, S., Kasl, P., Hartogensis, W., Dilchert, S., Hecht, F. M., Mason, A. E., Wang, E. J., et al. (2026) · Communications Medicine · doi:10.1038/s43856-026-01501-0
Patil, G. G., Khatib, M. N., Rawekar, A., Godse, D. A., & Umate, L. (2026) · JMIR Research Protocols · doi:10.2196/91185
Early autonomic neuropathy in prediabetes: an overlooked driver of cardiometabolic risk
Concepción-Zavaleta, M., Fuentes-Mendoza, J., Concepción-Urteaga, L., Castillo-Balderas, S. A., Siguas, J. C. M., Paz-Ibarra, J., & Quiroz-Aldave, J. (2026) · Expert Review of Cardiovascular Therapy · doi:10.1080/14779072.2026.2696292
Patil, G. G., Khatib, M. N., Rawekar, A., Godse, D. A., & Umate, L. (2026) · doi:10.2196/preprints.110269
- Authors
- Verma, S., Alam, R., Ahmad, I., Singla, D., Ali, K., & Hussain, M. E.
- Affiliations
- Jamia Millia Islamia (IN)
- Corresponding author
- Verma, Shalini
- Venue
- Journal of Diabetes & Metabolic Disorders
- Published
- 2018-09-08
- Volume
- 17
- Issue
- 2
- Pages
- 149-158
- ISSN
- 2251-6581 (ISSN-L)
- PMC
- PMC6405381
- OpenAlex
- W2889577322
- Cited by
- 20
- References
- 54
- Citations by year
- 2026: 4 · 2025: 1 · 2024: 2 · 2022: 5 · 2021: 3 · 2020: 3 · 2019: 2
- FWCI
- 1.51
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Diabetes & Metabolic Disorders (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart Rate Variability and Autonomic Control
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- type 2 diabetes, cardiac autonomic neuropathy, glycemic control, disease duration, oxidative stress, heart rate recovery, heart rate variability, antioxidant enzymes, catalase, superoxide dismutase, nitric oxide, HbA1c
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review